TrialBritish journal of clinical pharmacology2012

The effects of febuxostat on the pharmacokinetic parameters of rosiglitazone, a CYP2C8 substrate.

Himanshu Naik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.